semaglutide essence EASL 2026 Targeting fibrosis and steatohepatitis through

Mistake 2: injecting at different times each week Related to mistake 1 but slightly different

In a recent online survey, N = 600 patients with T2D were asked to provide their treatment preferences regarding a once-daily oral GLP-1RA compared with a once-weekly injectable GLP-1RA

Patients should maintain adequate fluid intake and seek urgent medical review if they are unable to keep fluids down

Drug Makers Ignore More Significant Evidence in Trials The International Journal of Clinical Pharmacy highlighted a concerning association between semaglutide and adverse psychiatric events. Between January 2021 and May 2023, databases recorded 481 psychiatric events associated with GLP-1 medications and similar drugs, including 9 deaths and 11 life-threatening outcomes. Poison control centers reported nearly 3,000 calls involving semaglutide in less than a year

A dedicated trial in adults with obesity found no evidence of delayed gastric emptying at week 20 for semaglutide 2.4 mg, while still showing reduced appetite, reduced cravings, and lower energy intake